Decentralized Trials Ease Enrollment In Rare Disease Studies

Panel discussion illustrated how decentralized approaches can expand the possibilities of studies in rare diseases, such as cancers with rare genomic alterations.

Medical app
A recent webinar focused on decentralized trial opportunities, especially in rare diseases • Source: Shutterstock

More from Clinical Trials

More from R&D